Skip to main content

Table 1 Characteristics of enrolled patients

From: Estimated influence of a novel biocompatible dialysis membrane on vascular events in dialysis patients with diabetic nephropathy: a prospective randomized controlled pilot study

 

NV group

PS group

P value

Number of patients

25

25

–

Sex (male/female)

17/8

18/7

0.76

Age (years)

64.8 ± 9.0

63.9 ± 10.2

0.59

Duration of dialysis (years)

6.5 ± 3.6

6.6 ± 5.1

0.69

Insulin administration (Y/N)

10/15

10/15

1.00

Duration of diabetic nephropathy (years)

19.1 ± 13.0

13.9 ± 10.9

0.13

Administration of DPP-4 inhibitors (Y/N)

16/9

13/12

0.39

Administration of antihypertensive agents (Y/N)

16/9

17/8

0.76

Body weight (kg)

60.8 ± 12.1

58.7 ± 11.7

0.75

HbA1c (%)

6.2 ± 1.0

6.2 ± 0.8

0.96

Hb (g/dL)

10.3 ± 0.7

10.5 ± 0.6

0.89

Serum albumin (g/dL)

3.9 ± 0.4

3.9 ± 0.3

0.74

Surface area of dialyzer (m2)

1.8 ± 0.4

1.8 ± 0.4

0.53

  1. Results of parameters were evaluated in enrolled patients and are presented as the mean ± standard deviation